GlassScriptPhysician profile
Karan R Moseley
NPI 1568416188
$744.02
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $409 · 2021: $43.60 · 2022: $96.24.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $255.87 | 2019-2022 | |
| Exeltis, USA INC. | $111.74 | 2020-2022 | |
| Millicent US INC | $95.93 | 2020 | |
| Intuitive Surgical, INC. | $65.00 | 2019 | |
| Abbvie INC. | $56.85 | 2019-2022 | |
| Therapeuticsmd, INC. | $32.34 | 2020 | |
| Avion Pharmaceuticals | $31.06 | 2019-2020 | |
| Lupin INC. | $22.86 | 2019 | |
| Duchesnay USA Incorporated | $22.39 | 2019 | |
| Lsi Solutions INC | $16.93 | 2019 | |
| Allergan, INC. | $16.70 | 2019 | |
| Myovant Sciences INC. | $16.35 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karan Moseley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.